110 related articles for article (PubMed ID: 17561390)
21. Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings.
Tran N; Bharaj BS; Diamandis EP; Smith M; Li BD; Yu H
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2133-40. PubMed ID: 15598771
[TBL] [Abstract][Full Text] [Related]
22. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K
Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723
[TBL] [Abstract][Full Text] [Related]
23. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
Huang CS; Kuo SH; Lien HC; Yang SY; You SL; Shen CY; Lin CH; Lu YS; Chang KJ
Oncologist; 2008 Jul; 13(7):751-60. PubMed ID: 18614591
[TBL] [Abstract][Full Text] [Related]
24. Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
Fehringer G; Boyd NF; Knight JA; Paterson AD; Dite GS; Giles GG; Southey MC; Andrulis IL; Hopper JL; Ozcelik H
Breast Cancer Res Treat; 2009 Nov; 118(2):415-24. PubMed ID: 19229608
[TBL] [Abstract][Full Text] [Related]
25. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
[TBL] [Abstract][Full Text] [Related]
26. Association of CA repeat polymorphism at intron 1 of insulin-like growth factor (IGF-I) gene with circulating IGF-I concentration, growth, and fatness in swine.
Estany J; Tor M; Villalba D; Bosch L; Gallardo D; Jiménez N; Altet L; Noguera JL; Reixach J; Amills M; Sánchez A
Physiol Genomics; 2007 Oct; 31(2):236-43. PubMed ID: 17579179
[TBL] [Abstract][Full Text] [Related]
27. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor I (CA) repeats are associated with higher melanoma's Breslow index but not associated with the presence of the melanoma. A pilot study.
Santonocito C; Paradisi A; Capizzi R; Concolino P; Lavieri MM; Lanza Silveri S; De Luca D; Catricalà C; Di Carlo A; Zuppi C; Ameglio F; Capoluongo E
Clin Chim Acta; 2008 Apr; 390(1-2):104-9. PubMed ID: 18237549
[TBL] [Abstract][Full Text] [Related]
29. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
Zubor P; Kajo K; Stanclova A; Szunyogh N; Galo S; Dussan CA; Minarik G; Visnovsky J; Danko J
Eur J Cancer Prev; 2008 Feb; 17(1):33-8. PubMed ID: 18090908
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women.
Olsen A; Autrup H; Sørensen M; Overvad K; Tjønneland A
Eur J Cancer Prev; 2008 Jun; 17(3):225-9. PubMed ID: 18414193
[TBL] [Abstract][Full Text] [Related]
31. The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer.
Chong YM; Subramanian A; Sharma AK; Mokbel K
Anticancer Res; 2007; 27(3B):1617-24. PubMed ID: 17595785
[TBL] [Abstract][Full Text] [Related]
32. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer.
Missmer SA; Haiman CA; Hunter DJ; Willett WC; Colditz GA; Speizer FE; Pollak MN; Hankinson SE
Int J Cancer; 2002 Jul; 100(3):332-6. PubMed ID: 12115549
[TBL] [Abstract][Full Text] [Related]
33. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
[TBL] [Abstract][Full Text] [Related]
34. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
[TBL] [Abstract][Full Text] [Related]
35. Sulfotransferase1A1 and risk of postmenopausal breast cancer.
Jerevall PL; Ahmadi A; Bergman M; Stål O; Wingren S
Anticancer Res; 2005; 25(3c):2515-7. PubMed ID: 16080486
[TBL] [Abstract][Full Text] [Related]
36. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
37. Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk.
Jung SY; Ho G; Rohan T; Strickler H; Bea J; Papp J; Sobel E; Zhang ZF; Crandall C
Breast Cancer Res Treat; 2017 Jul; 164(2):475-495. PubMed ID: 28478612
[TBL] [Abstract][Full Text] [Related]
38. Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis.
Pasanisi P; Venturelli E; Morelli D; Fontana L; Secreto G; Berrino F
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1719-22. PubMed ID: 18628423
[TBL] [Abstract][Full Text] [Related]
39. HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis.
Tao W; Wang C; Han R; Jiang H
Breast Cancer Res Treat; 2009 Mar; 114(2):371-6. PubMed ID: 18438707
[TBL] [Abstract][Full Text] [Related]
40. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
